{"name":"Pharmasset","slug":"pharmasset","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Racivir","genericName":"Racivir","slug":"racivir","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"Racivir","genericName":"Racivir","slug":"racivir","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxQdTh3UU84Z1JGUm0wRDhDZWRnVXlKczY4UjNYN09VNUJuZHV0eDlkWmFwdGFCUkw5aDAzNlZXc2F2Yk5BTTZSV25lQ2JMcXZ5dDVTanBFb2JSaklTZHNFX0x1OUxZQm5FYjRnalh0T01mYW9mRmI3ZFA2d0luZ3VYa3pCSGhWWDhCX0E4?oc=5","date":"2025-02-05","type":"deal","source":"BioWorld News","summary":"Few biopharma mega-mergers hit the jackpot - BioWorld News","headline":"Few biopharma mega-mergers hit the jackpot","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiaEFVX3lxTE9QMmFJWHJoTC1uRDdUUFpZQXVmOEx3REhJdUk3azhOTURSNzVDekNpYnNhbzJFVWMwelRURmQwQ29fQXd2T2I1TnowbHFWcVNMbW01aVlycE1Wc1VTdEphS2I1Z25OUHB1?oc=5","date":"2024-05-21","type":"pipeline","source":"bucksco.today","summary":"Mike Sofia, Scientist Behind Hepatitis C Drug, Retires from Warminster-Based Arbutus Biopharma - bucksco.today","headline":"Mike Sofia, Scientist Behind Hepatitis C Drug, Retires from Warminster-Based Arbutus Biopharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxQVkwwX2R6NV9OTEo2OEhnUU52NFVsSjZ4OGNIcDJuOWlSazUtRnk4YzdXbmZmQ0VEMEMwLVg3bXd5MGYxenJOUDd3OG1rTHZMeTRYTFpIWXUtMG9Cd3Y1NUtTaWpCVWdRWnFDdnF4YjkzbDlpVWZuZXpyZXdYdi1aRVBheUttWHljX1Rna1htSFN3Yl9DMnE5a2JzTQ?oc=5","date":"2020-08-08","type":"earnings","source":"The Wire Science","summary":"A Brief History of Pharmaceutical Profiteering - The Wire Science","headline":"A Brief History of Pharmaceutical Profiteering","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMickFVX3lxTFBNVmxvTlJ3OThLODBXdV9Ua054Ty1JbW5OWjc4VW1SYmJvZjRNZi1FUENpSmg0NzBTTlhMaUZQaXl0Qk1Ua2ZrOHNyd2M5MHhJajk1Z0V3OGdXS2tLa2Q5U2lEMWVGSldmRmx2Sld4R2ppdw?oc=5","date":"2018-12-04","type":"pipeline","source":"Emory University","summary":"Emory HIV/AIDS drug inventor, entrepreneur decorated with French Legion of Honor | Emory University | Atlanta GA - Emory University","headline":"Emory HIV/AIDS drug inventor, entrepreneur decorated with French Legion of Honor | Emory University | Atlanta GA","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxPRUJPc1p0VDVFeno5Wk9iMlVlNl9kWEhDRDNHNVFGVmc2WXV0RU5sU0c4MFhLV2RGc0otRkVHS2hqdFZCbVIzdDhIRF8zZ1lVTVpPV1NfR2FNOWJiRHBUWVk4eFZWRWJ2VHNSeXdWQi1WSzhfMW5ua0NzT016ZWtHZGVKeFFNQ2d2T202RnBHcU9yY29tNEdqRUsyalppQkc4enhwWmlhR0JUYlk?oc=5","date":"2018-04-27","type":"patent","source":"Fierce Pharma","summary":"Merck lawyer's misdeeds tainted Gilead patent fight, court rules—and cost the company $200M - Fierce Pharma","headline":"Merck lawyer's misdeeds tainted Gilead patent fight, court rules—and cost the company $200M","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxQVjBiSnA0cDN4aHlYdGd6ekJNbDRaMHpTTFdSQ3J2Z2VYYXJGTmRRbEk4b1VZV3FCU3FWYlhITUJzeEtwLTI2MEEtQmhHd29yaEQ5RE5IeHlXeDBsQnFUYzlaUkZtUWZLb1EtOGEzV0RiTFRnVzFvdkQ4ck9vYWxyNF83V1ZVVVp2Sm05bjVrRDFrZw?oc=5","date":"2017-12-04","type":"deal","source":"BioPharma Dive","summary":"Deal of the Year: Gilead Buys Kite Pharma - BioPharma Dive","headline":"Deal of the Year: Gilead Buys Kite Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxPQU1XMjRzdzBRQkpWZGFfM1JKZUhRcmZlemtnN3BkLTlCaDFzSnVYU0FSV29fZEpkdW0wS0lRUDJQaGlJLTFjUkNYaVFfQ0pnY3FBdUFsS2dxbVdqTG1FQzZMNlJUWHlEZnR6Wi1TVEZwZWtNcFdDSjFpcEhNZ3BaRWpvNnV2Zw?oc=5","date":"2017-08-28","type":"deal","source":"C&EN","summary":"Gilead to acquire Kite Pharma for $11.9 billion - C&EN","headline":"Gilead to acquire Kite Pharma for $11.9 billion - C&EN","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxPZ0hwRTBCcGJFOGo1czBPdGxJYjVYRFpaUEpMWElEX0VMVERhcTlSSU16dTZ3X05XLUtjejh4TWxteV9tM2N1UkY4YlkzYm5Sa0MxNXZ4UmwtSWVuaDZERFFQaWxCX3ZxbjVMMk9adFRwX2NhNEs3WmQ2SVdjN3VwbjB3aEwwc1pBbTJkcUl6V0ItSkRybGRVWDhxUEVxN09ENHVqaHRkeFI2dHpfZUtIMC1tcw?oc=5","date":"2017-08-28","type":"deal","source":"Bloomberg.com","summary":"Gilead Tries to Repeat Home Run With $11.9 Billion Kite Deal - Bloomberg.com","headline":"Gilead Tries to Repeat Home Run With $11.9 Billion Kite Deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTE9WbThyLTZKejFYWlFKYTlaM012UmI0Q1YzcDg3c1JSRkROVkp1cHo3bUk5QmVINy1IVnRQdDB4eFBrTmI1RDJETWViLVlSLTFjNFdfM2dVTTBwbFhySEJ3cm5xbDZVYXJJdThqR0hRWFhDTld2UmdsVA?oc=5","date":"2017-02-08","type":"pipeline","source":"pharmaphorum","summary":"Can Gilead find another Pharmasset in 2017? - pharmaphorum","headline":"Can Gilead find another Pharmasset in 2017?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxOczNraE9jVGFOZFZ1eHR2WXh3ZGtWYl9ET2dQTXV4VVdfMmtkYzFyVXhXdHo1VERxOF9PTzJmZTdpdWJRS2JISllHd0RaUlFfbmZ3Z0xLeTFHNnZEZy10Umx5c2hzX3c2U2hUckstWlQxY1lETkdEVkljck9BNWV4R3NvZ1B6N2w0SndROQ?oc=5","date":"2017-01-20","type":"pipeline","source":"qz.com","summary":"The staggering success of Gilead’s hepatitis drugs, in one chart - qz.com","headline":"The staggering success of Gilead’s hepatitis drugs, in one chart","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYEFVX3lxTE5fSWpKYTFPeEZqYXA4dHd5N0M4LTQyWXgtUjR1bU1XQ25UWklQQnNPcWpiRXQtc29iTG5tNVlxR2tpY2Zod25pTDNPRlBRQ1ZSdi1Ra1pGaWNmYms2ZW1SWQ?oc=5","date":"2013-04-24","type":"pipeline","source":"NEJM","summary":"Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options - NEJM","headline":"Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxOZ3dfMVJVbzNDWXR0WG11ZXNiWlRFQkhkelZpNG5mNFlFU0lYWkFackxCMUtCMXI2TlF1VG9EV3djODNkR3pJRV93THFqQkFyM0F0OXVCVXdsUDNuc3ZfZDhUOHpFN0tPbHpINVU1dDk1RjdaLXFaOVl2aWtUc0tZdFRNMllkejVVbFZCSHh4RUtBb0RvRmdvYlRQNl9vcldyRXo5d204WkJoSEpmOWJvbFVB?oc=5","date":"2012-01-06","type":"deal","source":"RTTNews","summary":"Gilead Gets Early Termination Of HSR Waiting Period For Pharmasset Deal - RTTNews","headline":"Gilead Gets Early Termination Of HSR Waiting Period For Pharmasset Deal","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}